ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,607Medicare Part D Prescriptions Filled, Including Refills

Rank: 122 out of 939

$973K Total Retail Price of All Prescriptions

Rank: 50 out of 939

756 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 756 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 756 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 7,516 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 928 379 S3 1 1
PRAVASTATIN SODIUM 499 304 2 13
LISINOPRIL 402 250 3 3
LEVOTHYROXINE SODIUM 363 280 4 4
OXYCODONE HCL 354 57 S2 5 67
OMEPRAZOLE 330 179 6 5
METFORMIN HCL 284 223 7 8
SIMVASTATIN 252 199 8 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 242 138 9 23
ZOLPIDEM TARTRATE 242 108 9 20
MORPHINE SULFATE ER 232 33 S2 11 113
FUROSEMIDE 226 134 12 7
AMLODIPINE BESYLATE 219 161 13 6
CARISOPRODOL 219 23 R 13 51
ATORVASTATIN CALCIUM 196 120 15 22
TRAMADOL HCL 196 112 15 16
GABAPENTIN 184 88 17 11
METHADONE HCL 174 28 S2 18 109
TRAZODONE HCL 164 72 19 26
CITALOPRAM HBR 163 63 20 15
METOPROLOL TARTRATE 162 91 21 10
NEXIUM 160 56 22 18
HYDROCHLOROTHIAZIDE 159 115 23 12
AMITRIPTYLINE HCL 154 50 R 24 38
POTASSIUM CHLORIDE 147 72 25 9
ATENOLOL 141 91 26 19
CYCLOBENZAPRINE HCL 133 16 R 27 36
ADVAIR DISKUS 129 46 28 60
TAMSULOSIN HCL 125 105 29 27
DONEPEZIL HCL 123 121 30 30
PROAIR HFA 113 29 31 41
PROMETHAZINE HCL 109 24 R 32 68
CARVEDILOL 106 69 33 25
HYDROMORPHONE HCL 106 0 S2 33 208
CEFPROZIL 104 50 35 213
ALENDRONATE SODIUM 102 67 36 40
VENTOLIN HFA 100 17 37 80
FLUOXETINE HCL 98 30 38 47
RANITIDINE HCL 91 44 39 35
MELOXICAM 90 40 40 14
PREDNISONE 90 46 40 42
INDAPAMIDE 89 70 42 173
ESTRADIOL 85 25 R 43 79
CYMBALTA 85 25 43 44
LOSARTAN POTASSIUM 84 66 45 29
NADOLOL 83 46 46 281
CRESTOR 82 70 47 34
PLAVIX 81 47 48 48
LANSOPRAZOLE 81 28 48 177
GLIMEPIRIDE 79 56 50 37
MIRTAZAPINE 79 23 50 56
PANTOPRAZOLE SODIUM 78 31 52 66
OXYCODONE HCL-ACETAMINOPHEN 76 17 S2 53 107
WARFARIN SODIUM 74 51 54 17
CLOPIDOGREL 73 42 55 28
VENLAFAXINE HCL ER 73 26 55 121
SERTRALINE HCL 73 46 55 24
KLOR-CON M20 70 56 58 90
DIOVAN 70 51 58 50
TRIAMTERENE-HCTZ 68 34 60 33
FLUTICASONE PROPIONATE 66 37 61 43
ACEBUTOLOL HCL 64 51 62 320
METOPROLOL SUCCINATE 61 50 63 21
ALLOPURINOL 60 45 64 31
QUINAPRIL HCL 60 53 64 133
ROPINIROLE HCL 57 54 66 78
LYRICA 57 12 66 63
VERAPAMIL ER 56 23 68 85
SPIRIVA 56 39 68 73
NAMENDA 55 55 70 49
DIGOXIN 55 53 70 45
JANUVIA 54 25 72 110
NAPROXEN 54 21 72 72
AMLODIPINE BESYLATE-BENAZEPRIL 53 33 74 58
ACTOPLUS MET 52 21 75 343
ESCITALOPRAM OXALATE 51 20 76 61
TOPIRAMATE 51 0 76 154
LOVASTATIN 51 41 76 46
OXYCONTIN 50 13 S2 79 161
CLONIDINE HCL 50 22 79 39
CELEBREX 50 28 79 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.